Nateglinide

From WikiMD.org
Jump to navigation Jump to search

Nateglinide (pronunciation: /nəˈtɛɡlɪnaɪd/) is an oral medication used for the treatment of Type 2 diabetes. It belongs to the class of drugs known as meglitinides, which work by stimulating the release of insulin from the pancreas.

Etymology

The term "Nateglinide" is derived from its chemical name, which is 1-[[[2-[(3-phenyl-1,2,4-thiadiazol-5-yl)methyl]phenyl]amino]]acetyl]-D-glucitol. The "-glucitol" suffix indicates that the compound is a sugar alcohol, while the "nate" prefix is derived from the Latin "natus", meaning "born". The "gli" in the middle of the name is a common element in the names of drugs used to treat diabetes, indicating that the drug is a glucose-lowering agent.

Usage

Nateglinide is used in conjunction with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is usually taken three times a day, before each main meal. Nateglinide works by stimulating the body to produce more insulin, a natural substance that allows the body to properly use sugar from the diet.

Side Effects

Common side effects of Nateglinide include hypoglycemia (low blood sugar), dizziness, weight gain, joint pain, and flu-like symptoms. If these side effects persist or worsen, patients are advised to contact their healthcare provider immediately.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski